4 hours Integra LifeSciences (NASDAQ:IART) Stock Rating Upgraded by BTIG Research MarketBeat
BTIG Research upgraded Integra LifeSciences from a “sell” rating to a “neutral” rating in a research note on Monday.
BTIG Research upgraded Integra LifeSciences from a “sell” rating to a “neutral” rating in a research note on Monday.